Literature DB >> 8504743

Effects of neonatal estrogen exposure on prostatic secretory genes and their correlation with androgen receptor expression in the separate prostate lobes of the adult rat.

G S Prins1, C Woodham, M Lepinske, L Birch.   

Abstract

Brief administration of estrogen to newborn rats permanently restricts prostatic growth and testosterone sensitivity in adulthood. Previous work demonstrated that neonatal exposure to estradiol benzoate produced lobe-specific imprints in prostatic androgen receptor (AR) expression. Epithelial cell AR was markedly reduced or absent in the adult ventral and dorsal lobes, which correlated with a lack of epithelial differentiation and responsiveness. While the lateral lobe also showed reduced growth and testosterone responsiveness after neonatal estradiol benzoate, normal cell differentiation and AR levels were observed within the adult epithelium. To determine the impact that these receptor imprints have on the functional capacity of adult tissue, we herein examined the expression of lobe-specific, androgen-dependent, or androgen-responsive secretory genes in prostates of rats given neonatal estradiol benzoate and directly compared this with epithelial cell AR using histological techniques. Sprague-Dawley rat pups were given 25 micrograms estradiol benzoate or oil on days 1, 3, and 5 and killed on day 90. Prostatic mRNA was analyzed using Northern blots and in situ hybridization. Ventral lobe mRNA was hybridized with a prostate binding protein (PBP) cDNA probe, while lateral and dorsal mRNA were hybridized with RWB (seminal vesicle secretory protein or SVS-II), probasin, and DP1 cDNA probes. Sections adjacent to those used for in situ hybridization were stained for AR by immunocytochemistry. Neonatal estradiol benzoate significantly reduced ventral lobe PBP message on Northern blots, and this was not restored with adult testosterone administration. There was a direct correlation between epithelial cell AR and PBP expression, in that PBP message and protein were only present in epithelial AR-positive cells and were absent in all AR-negative epithelium. In the lateral prostate, probasin expression was unaffected by neonatal estradiol benzoate, whereas RWB was slightly reduced using Northern analysis. By in situ hybridization, these messages were observed at normal levels in lateral lobe epithelial cells of estrogenized rats, which directly correlated with the presence of AR in those cells. In the dorsal prostate, different response patterns to neonatal estradiol benzoate were found for the three secretory genes analyzed. On Northern blots, DP1 message significantly declined, probasin mRNA was modestly suppressed, and RWB expression was significantly elevated compared to those in control tissue. In situ hybridization revealed that RWB expression in estrogenized dorsal lobes was amplified in AR-positive epithelial cells, whereas AR-negative cells appeared unaltered. In summary, prostatic functional activity after neonatal estradiol benzoate exposure is affected in a lobe-specific manner, which correlates with the AR imprints in the separate lobes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504743     DOI: 10.1210/endo.132.6.8504743

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

Review 1.  Developmental estrogen exposures predispose to prostate carcinogenesis with aging.

Authors:  Gail S Prins; Lynn Birch; Wan-Yee Tang; Shuk-Mei Ho
Journal:  Reprod Toxicol       Date:  2006-10-24       Impact factor: 3.143

Review 2.  The role of estrogens in normal and abnormal development of the prostate gland.

Authors:  Gail S Prins; Liwei Huang; Lynn Birch; Yongbing Pu
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

3.  Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late life.

Authors:  Joseph John Bianco; Stephen John McPherson; Hong Wang; Gail S Prins; Gail Petuna Risbridger
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 4.  Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk.

Authors:  Wen-Yang Hu; Guang-Bin Shi; Dan-Ping Hu; Jason L Nelles; Gail S Prins
Journal:  Mol Cell Endocrinol       Date:  2011-09-05       Impact factor: 4.102

5.  Early-life estrogens and prostate cancer in an animal model.

Authors:  G S Prins; S-M Ho
Journal:  J Dev Orig Health Dis       Date:  2010-12       Impact factor: 2.401

6.  Inhibition of growth and cell cycle arrest of ARCaP human prostate cancer cells by ectopic expression of ER-alpha.

Authors:  Q Ye; B Cinar; M Edlund; L W Chung; H E Zhau
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

7.  Aggressive prostate cancer is prevented in ERαKO mice and stimulated in ERβKO TRAMP mice.

Authors:  Anna Slusarz; Glenn A Jackson; J Kevin Day; Nader S Shenouda; Jennifer L Bogener; Jim D Browning; Kevin L Fritsche; Ruth S MacDonald; Cynthia L Besch-Williford; Dennis B Lubahn
Journal:  Endocrinology       Date:  2012-06-29       Impact factor: 4.736

8.  Oestrogen supplementation following castration promotes stromal remodelling and histopathological alterations in the Mongolian gerbil ventral prostate.

Authors:  Wellerson Rodrigo Scarano; Daniel Emídio de Sousa; Silvana Gisele Pegorin Campos; Lara Silvia Corradi; Patricia Simone Leite Vilamaior; Sebastião Roberto Taboga
Journal:  Int J Exp Pathol       Date:  2007-11-10       Impact factor: 1.925

9.  Novel biomarkers for risk of prostate cancer: results from a case-control study.

Authors:  Li Yang; Nilesh W Gaikwad; Jane Meza; Ercole L Cavalieri; Paola Muti; Bruce Trock; Eleanor G Rogan
Journal:  Prostate       Date:  2009-01-01       Impact factor: 4.104

10.  Sonic hedgehog-patched Gli signaling in the developing rat prostate gland: lobe-specific suppression by neonatal estrogens reduces ductal growth and branching.

Authors:  Yongbing Pu; Liwei Huang; Gail S Prins
Journal:  Dev Biol       Date:  2004-09-15       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.